Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Gil, K. Kałwak, A. Piekarska, J. Góra-tybor, A. Wierzbowska, M. Bieniaszewska, I. Hus, T. Szczepański, S. Giebel, E. Lech-Maranda, J. Styczyński (2020)
Antifungal management in adults and children with hematological malignancies or undergoing hematopoietic cell transplantation: recommendations of Polish Society of Hematology and Blood Transfusion, Polish Society of Pediatric Oncology and Hematology, and Polish Adult Leukemia Study Group, 2020Acta Haematologica Polonica, 51
J. Styczyński (2020)
Hematology and transfusion medicine facing COVID-19: perspectives beyond the pandemicActa Haematologica Polonica, 51
O. Hrusak, T. Kalina, J. Wolf, A. Balduzzi, M. Provenzi, C. Rizzari, S. Rives, M. Carlavilla, M. Alonso, N. Domínguez-Pinilla, J. Bourquin, K. Schmiegelow, A. Attarbaschi, P. Grillner, K. Mellgren, J. Bosch, R. Pieters, T. Brozou, A. Borkhardt, G. Escherich, M. Lauten, M. Stanulla, O. Smith, A. Yeoh, S. Elitzur, A. Vora, Chi-kong Li, H. Ariffin, A. Kolenová, Luciano Dallapozza, R. Farah, J. Lazic, A. Manabe, J. Styczyński, G. Kovács, G. Ottóffy, M. Felice, B. Buldini, V. Conter, J. Starý, M. Schrappe (2020)
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatmentEuropean Journal of Cancer, 132
M. Cummings, M. Baldwin, D. Abrams, Samuel Jacobson, Benjamin Meyer, Elizabeth Balough, J. Aaron, J. Claassen, L. Rabbani, J. Hastie, Beth Hochman, J. Salazar‐Schicchi, Natalie Yip, D. Brodie, M. O’Donnell (2020)
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort studymedRxiv : the preprint server for health sciences
J. Styczyński (2019)
Infectious complications in children and adults with hematological malignanciesActa Haematologica Polonica, 50
Yuanyuan Dong, X. Mo, Yabin Hu, Xin Qi, F. Jiang, Zhongyi Jiang, Shilu Tong (2020)
Epidemiology of COVID-19 Among Children in ChinaPediatrics, 145
recipients, their donors, and patients undergoing CAR T-cell therapy
A. Balduzzi, Erica Brivio, A. Rovelli, C. Rizzari, S. Gasperini, M. Melzi, V. Conter, A. Biondi (2020)
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote paratiBone Marrow Transplantation, 55
(2018)
Pediatric oncology and hematology in Poland. Pediatr Pol 2018;93:451–61
J. Styczyński (2019)
ABC of viral infections in hematology: focus on herpesvirusesActa Haematologica Polonica, 50
AbstractIntroductionEpidemiological analysis of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections in pediatric hematology and oncology (PHO) and hematopoietic cell transplant (HCT) centers in a Polish nationwide study, as well as analysis of the preventive strategies in these centers.MethodsAll of the 18 PHO/HCT centers participated in eight surveys and questionnaires conducted over the first 5 months of the SARS-CoV-2/coronavirus disease 2019 (COVID-19) pandemic in Poland. Epidemiological data were collected at eight regular time points, and the strategy of preventive management was done once after 4 months of the pandemic.ResultsDuring this analyzed period, eight patients were positive for SARS-CoV-2. The estimated incidence of SARS-CoV-2 positivity in Polish PHO/HCT centers was 0.5%. After exclusion of HCT patients (with one patient being infected), the estimated incidence of SARSCoV-2 positivity was between 0.5 and 0.6%. In all but one case, the course of COVID-19 was asymptomatic or mild, and it was moderate in one case. None of them developed SARS or respiratory insufficiency, none of them required treatment in the intensive care unit (ICU), and no patient died due to SARS-CoV-2 infection. As of July 1, parents staying in the hospital together with their children were regularly tested for the virus in 13 centers. Asymptomatic healthcare personnel were regularly tested for the virus in seven centers.ConclusionsThe estimated incidence of SARS-CoV-2 infection among PHO/HCT patients is lower than in Western Europe; however, these patients cannot be regarded as a low-risk group. The low COVID-19 incidence should be interpreted as a result of strictly and continuously implemented detailed preventive measures in the PHO/HCT wards and in hospitals.
Acta Haematologica Polonica – de Gruyter
Published: Dec 1, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.